Filing Details

Accession Number:
0000899243-22-039463
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-28 20:00:15
Reporting Period:
2022-12-23
Accepted Time:
2022-12-28 20:00:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Madrigal Pharmaceuticals Inc. MDGL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1806949 Remy Sukhija C/O Madrigal Pharmaceuticals, Inc.
200 Barr Harbor Drive, Suite 200
West Conshohocken PA 19428
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-23 30,000 $60.26 30,000 No 4 M Direct
Common Stock Disposition 2022-12-23 593 $266.04 29,407 No 4 S Direct
Common Stock Disposition 2022-12-23 1,107 $267.47 28,300 No 4 S Direct
Common Stock Disposition 2022-12-23 1,913 $268.50 26,387 No 4 S Direct
Common Stock Disposition 2022-12-23 1,476 $269.61 24,911 No 4 S Direct
Common Stock Disposition 2022-12-23 2,069 $270.56 22,842 No 4 S Direct
Common Stock Disposition 2022-12-23 2,084 $271.54 20,758 No 4 S Direct
Common Stock Disposition 2022-12-23 5,534 $272.68 15,224 No 4 S Direct
Common Stock Disposition 2022-12-23 2,471 $273.54 12,753 No 4 S Direct
Common Stock Disposition 2022-12-23 3,019 $274.56 9,734 No 4 S Direct
Common Stock Disposition 2022-12-23 811 $275.70 8,923 No 4 S Direct
Common Stock Disposition 2022-12-23 700 $276.67 8,223 No 4 S Direct
Common Stock Disposition 2022-12-23 700 $277.83 7,523 No 4 S Direct
Common Stock Disposition 2022-12-23 3,003 $279.15 4,520 No 4 S Direct
Common Stock Disposition 2022-12-23 2,620 $279.96 1,900 No 4 S Direct
Common Stock Disposition 2022-12-23 1,000 $280.92 900 No 4 S Direct
Common Stock Disposition 2022-12-23 400 $282.13 500 No 4 S Direct
Common Stock Disposition 2022-12-23 400 $283.43 100 No 4 S Direct
Common Stock Disposition 2022-12-23 100 $284.65 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-12-23 30,000 $0.00 30,000 $60.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 2030-04-01 No 4 M Direct
Footnotes
  1. All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. After giving effect to these transactions, the reporting person's Rule 10b5-1 trading plan has been concluded and no more trading will be conducted thereunder.
  2. All shares issued pursuant to the exercise of the options reported herein represent 30,000 shares underlying an overall option award of 60,000 shares. All exercised options had vested. As to the overall option for 60,000 shares, 25% of the shares underlying the option vested on April 1, 2021 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.76 to $266.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.98 to $267.85, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.00 to $268.82, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.01 to $269.95, inclusive.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.04 to $271.01, inclusive.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.04 to $272.01, inclusive.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.04 to $273.02, inclusive.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.04 to $274.01, inclusive.
  11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.19 to $275.13, inclusive.
  12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.24 to $276.23, inclusive.
  13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.40 to $277.31, inclusive.
  14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.49 to $278.13, inclusive.
  15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $278.53 to $279.50, inclusive.
  16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.56 to $280.42, inclusive.
  17. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.61 to $281.44, inclusive.
  18. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.00 to $282.20, inclusive.
  19. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.11 to $283.83, inclusive.